Lipid profiling of the therapeutic effects of berberine in patients with nonalcoholic fatty liver disease
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Lipid profiling of the therapeutic effects of berberine in patients with nonalcoholic fatty liver disease
Authors
Keywords
Berberine, Nonalcoholic fatty liver disease, Lipidomic approach, Sphingolipids, Ceramide
Journal
Journal of Translational Medicine
Volume 14, Issue 1, Pages -
Publisher
Springer Nature
Online
2016-09-15
DOI
10.1186/s12967-016-0982-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Exercise Metabolism
- (2015) Nikla Emambokus et al. Cell Metabolism
- Efficacy of Berberine in Patients with Non-Alcoholic Fatty Liver Disease
- (2015) Hong-Mei Yan et al. PLoS One
- Ceramide as a Mediator of Non-Alcoholic Fatty Liver Disease and Associated Atherosclerosis
- (2015) Takhar Kasumov et al. PLoS One
- HPLC-MRM relative quantification analysis of fatty acids based on a novel derivatization strategy
- (2014) Tie Cai et al. ANALYST
- A Synthetic Biotinylated Peptide, BP21, Inhibits the Induction of mRNA Expression of Inflammatory Substances by Oxidized- and Lyso-Phosphatidylcholine
- (2014) Akira Sato et al. DRUG DEVELOPMENT RESEARCH
- The role of hepatic lipids in hepatic insulin resistance and type 2 diabetes
- (2014) Rachel J. Perry et al. NATURE
- Sphingolipid metabolites in inflammatory disease
- (2014) Michael Maceyka et al. NATURE
- Lipidomic profiling of plasma in patients with chronic hepatitis C infection
- (2013) Feng Qu et al. ANALYTICAL AND BIOANALYTICAL CHEMISTRY
- Finding the balance: The role ofS-adenosylmethionine and phosphatidylcholine metabolism in development of nonalcoholic fatty liver disease
- (2013) René L. Jacobs et al. HEPATOLOGY
- Ceramides and Glucosylceramides Are Independent Antagonists of Insulin Signaling
- (2013) Jose A. Chavez et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Inhibition of ceramidede novosynthesis reduces liver lipid accumulation in rats with nonalcoholic fatty liver disease
- (2013) Krzysztof Kurek et al. LIVER INTERNATIONAL
- Metabonomics Study of the Therapeutic Mechanism of Gynostemma pentaphyllum and Atorvastatin for Hyperlipidemia in Rats
- (2013) Miao Wang et al. PLoS One
- A role for sphingolipids in the pathophysiology of obesity-induced inflammation
- (2012) Benjamin T. Bikman CELLULAR AND MOLECULAR LIFE SCIENCES
- Role of ceramides in nonalcoholic fatty liver disease
- (2012) Mangesh Pagadala et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Safety, tolerability and sustained weight loss over 2 years with the once-daily human GLP-1 analog, liraglutide
- (2011) A Astrup et al. INTERNATIONAL JOURNAL OF OBESITY
- Sphingolipids and insulin resistance: the five Ws
- (2010) Scott A Summers CURRENT OPINION IN LIPIDOLOGY
- The plasma lipidomic signature of nonalcoholic steatohepatitis
- (2009) Puneet Puri et al. HEPATOLOGY
- Hepatocyte Nuclear Factor 1α Plays a Critical Role inPCSK9Gene Transcription and Regulation by the Natural Hypocholesterolemic Compound Berberine
- (2009) Hai Li et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Berberine decreases PCSK9 expression in HepG2 cells
- (2008) Jamie Cameron et al. ATHEROSCLEROSIS
- Sphingolipids, Insulin Resistance, and Metabolic Disease: New Insights fromin VivoManipulation of Sphingolipid Metabolism
- (2008) William L. Holland et al. ENDOCRINE REVIEWS
- Treatment of Type 2 Diabetes and Dyslipidemia with the Natural Plant Alkaloid Berberine
- (2008) Yifei Zhang et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Efficacy of berberine in patients with type 2 diabetes mellitus
- (2008) Jun Yin et al. METABOLISM-CLINICAL AND EXPERIMENTAL
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now